Articles with "colorectal carcinomas" as a keyword



Photo from wikipedia

The influence of tumour site on prognosis in metastatic colorectal carcinomas with primary tumour resection

Sign Up to like & get
recommendations!
Published in 2018 at "International Journal of Colorectal Disease"

DOI: 10.1007/s00384-018-3098-3

Abstract: PurposeThe aim of our study was to compare the characteristics and prognosis between right- and left-sided metastatic colorectal carcinomas.MethodsData from 937 patients with stage IV colorectal carcinomas (synchronous distant metastasis) who had a resection of… read more here.

Keywords: left sided; prognosis; colorectal carcinomas; carcinomas ... See more keywords
Photo from wikipedia

The role of appendectomy and cholecystectomy in the pathogenesis of colorectal carcinomas

Sign Up to like & get
recommendations!
Published in 2021 at "Annals of Medicine and Surgery"

DOI: 10.1016/j.amsu.2021.102991

Abstract: Background Several alterations in the gastrointestinal tract which occur after appendectomy or cholecystectomy have been suggested to raise the risk of developing colorectal carcinoma. Given the frequency that these procedures are performed, we sought to… read more here.

Keywords: colorectal carcinomas; risk; colorectal carcinoma; appendectomy cholecystectomy ... See more keywords
Photo from wikipedia

Clinicopathological features and phenotypic classification of de novo‐type colorectal carcinomas differ from those of colorectal carcinomas derived from flat adenomas

Sign Up to like & get
recommendations!
Published in 2019 at "Pathology International"

DOI: 10.1111/pin.12803

Abstract: Since adenoma components disappear with tumor progression, it is not known whether colorectal carcinomas (CRCs) are derived from an adenoma–carcinoma sequence or are de novo. We compared 38 cases of ≤10‐mm flat CRCs without an… read more here.

Keywords: type; crcs; colorectal carcinomas; novo type ... See more keywords
Photo from wikipedia

Case report: A combined immunotherapy strategy as a promising therapy for MSI-H colorectal carcinomas with multiple HPD risk factors

Sign Up to like & get
recommendations!
Published in 2023 at "Frontiers in Medicine"

DOI: 10.3389/fmed.2023.1051034

Abstract: Approximately 5% of advanced colorectal carcinomas (CRCs) and 12–15% of early CRCs are microsatellite instability-high (MSI-H) or mismatch repair-deficient (dMMR) tumors. Nowadays, PD-L1 inhibitors or combined CTLA4 inhibitors are the major strategies for advanced or… read more here.

Keywords: colorectal carcinomas; combined immunotherapy; risk factors; case ... See more keywords
Photo by bermixstudio from unsplash

Individual and Co-Expression Patterns of FAM83H and SCRIB at Diagnosis Are Associated with the Survival of Colorectal Carcinoma Patients

Sign Up to like & get
recommendations!
Published in 2022 at "Diagnostics"

DOI: 10.3390/diagnostics12071579

Abstract: Background: FAM83H is important in teeth development; however, an increasing number of reports have indicated a role for it in human cancers. FAM83H is involved in cancer progression in association with various oncogenic molecules, including… read more here.

Keywords: colorectal carcinoma; colorectal carcinomas; fam83h scrib; expression ... See more keywords
Photo from wikipedia

Clinicopathological features of T1 colorectal carcinomas with skip lymphovascular invasion.

Sign Up to like & get
recommendations!
Published in 2018 at "Oncology letters"

DOI: 10.3892/ol.2018.9527

Abstract: With recent advances in endoscopic treatment, many T1 colorectal carcinomas (CRCs) are resected endoscopically with a negative margin. However, some lesions exhibit skip lymphovascular invasion (SLVI), which is defined as the discontinuous foci of the… read more here.

Keywords: lymphovascular invasion; invasion; skip lymphovascular; colorectal carcinomas ... See more keywords